Academic Journal
Assessing the reliability of the PAK-LX HLA Class I bead in platelet transfusion compatibility testing.
| Τίτλος: | Assessing the reliability of the PAK-LX HLA Class I bead in platelet transfusion compatibility testing. |
|---|---|
| Συγγραφείς: | Enten H; American National Red Cross, USA., Liacini A; American National Red Cross, USA., Janes D; American National Red Cross, USA., Stedem R; American National Red Cross, USA., Gaule L; Atrium Health, USA., Berka N; American National Red Cross, USA. Electronic address: Noureddine.berka@redcross.org. |
| Πηγή: | Human immunology [Hum Immunol] 2026 May; Vol. 87 (5), pp. 111711. Date of Electronic Publication: 2026 Mar 13. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Elsevier/North-Holland Country of Publication: United States NLM ID: 8010936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1166 (Electronic) Linking ISSN: 01988859 NLM ISO Abbreviation: Hum Immunol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [New York] Elsevier/North-Holland. |
| Ιατρικοί όροι (MeSH): | Isoantibodies*/blood , Histocompatibility Antigens Class I*/immunology , Histocompatibility Testing*/methods , Blood Platelets*/immunology , Platelet Transfusion*, Humans ; Female ; Reproducibility of Results ; Male ; Adult ; Middle Aged |
| Περίληψη: | Purpose: PAK-LX, a Luminex-based assay for detecting platelet-specific glycoproteins and HLA class I antibodies, has shown limited reliability for HLA immunization. A prior study reported a 37% discrepancy compared to the single antigen bead (SAB) assay. The current study expands the cohort size to further investigate this discrepancy and uncover patterns that may explain the divergence. Methods: A total of 137 individuals from two American Red Cross Histocompatibility laboratories (Charlotte, NC and Portland, OR) were screened using both PAK-LX (Werfen, Inc) and SAB (ThermoFisher, Inc). Data included demographics, antibody positivity, discordance rates, mean fluorescence intensity (MFI), and calculated panel reactive antibody (cPRA). Results: SAB detected HLA class I antibodies in 73% of participants; 36% showed discordance, with 98% being PAK-LX false negatives. Mean cPRA among discordant cases was 29% (range: 2-96%). Missed antibodies had MFIs typically below 6,000 but ranged from 2,000 to 19,000. Conclusion: PAK-LX demonstrates reduced sensitivity for the detection of HLA class I antibodies compared with single-antigen bead (SAB) assays and may fail to identify HLA alloantibodies implicated in immune-mediated platelet transfusion refractoriness. Accordingly, PAK-LX should not be used as a standalone screening assay, and confirmatory testing with SAB is recommended when immune-mediated platelet refractoriness is suspected. (Copyright © 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.) |
| Competing Interests: | Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
| Contributed Indexing: | Keywords: Alloimmunization; Human leukocyte antigens; Platelet refractoriness |
| Substance Nomenclature: | 0 (Isoantibodies) 0 (Histocompatibility Antigens Class I) |
| Entry Date(s): | Date Created: 20260313 Date Completed: 20260710 Latest Revision: 20260710 |
| Update Code: | 20260711 |
| DOI: | 10.1016/j.humimm.2026.111711 |
| PMID: | 41825092 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.humimm.2026.111711? Name: ScienceDirect (all content) (s7799221) Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=18791166&ISBN=&volume=87&issue=5&date=20260501&spage=111711&pages=111711&title=Human immunology&atitle=Assessing%20the%20reliability%20of%20the%20PAK-LX%20HLA%20Class%20I%20bead%20in%20platelet%20transfusion%20compatibility%20testing.&aulast=Enten%20H&id=DOI:10.1016/j.humimm.2026.111711 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41825092 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessing the reliability of the PAK-LX HLA Class I bead in platelet transfusion compatibility testing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Enten+H%22">Enten H</searchLink>; American National Red Cross, USA.<br /><searchLink fieldCode="AU" term="%22Liacini+A%22">Liacini A</searchLink>; American National Red Cross, USA.<br /><searchLink fieldCode="AU" term="%22Janes+D%22">Janes D</searchLink>; American National Red Cross, USA.<br /><searchLink fieldCode="AU" term="%22Stedem+R%22">Stedem R</searchLink>; American National Red Cross, USA.<br /><searchLink fieldCode="AU" term="%22Gaule+L%22">Gaule L</searchLink>; Atrium Health, USA.<br /><searchLink fieldCode="AU" term="%22Berka+N%22">Berka N</searchLink>; American National Red Cross, USA. Electronic address: Noureddine.berka@redcross.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228010936%22">Human immunology</searchLink> [Hum Immunol] 2026 May; Vol. 87 (5), pp. 111711. <i>Date of Electronic Publication: </i>2026 Mar 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland%22">Elsevier/North-Holland </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8010936 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-1166 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201988859%22">01988859 </searchLink><i>NLM ISO Abbreviation: </i>Hum Immunol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: [New York] Elsevier/North-Holland. – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Isoantibodies%22">Isoantibodies*</searchLink>/<searchLink fieldCode="MM" term="%22Isoantibodies+blood%22">blood</searchLink> <br /><searchLink fieldCode="MM" term="%22Histocompatibility+Antigens+Class+I%22">Histocompatibility Antigens Class I*</searchLink>/<searchLink fieldCode="MM" term="%22Histocompatibility+Antigens+Class+I+immunology%22">immunology</searchLink> <br /><searchLink fieldCode="MM" term="%22Histocompatibility+Testing%22">Histocompatibility Testing*</searchLink>/<searchLink fieldCode="MM" term="%22Histocompatibility+Testing+methods%22">methods</searchLink> <br /><searchLink fieldCode="MM" term="%22Blood+Platelets%22">Blood Platelets*</searchLink>/<searchLink fieldCode="MM" term="%22Blood+Platelets+immunology%22">immunology</searchLink> <br /><searchLink fieldCode="MM" term="%22Platelet+Transfusion%22">Platelet Transfusion*</searchLink><br /><searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Reproducibility+of+Results%22">Reproducibility of Results</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Adult%22">Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Purpose: PAK-LX, a Luminex-based assay for detecting platelet-specific glycoproteins and HLA class I antibodies, has shown limited reliability for HLA immunization. A prior study reported a 37% discrepancy compared to the single antigen bead (SAB) assay. The current study expands the cohort size to further investigate this discrepancy and uncover patterns that may explain the divergence.<br />Methods: A total of 137 individuals from two American Red Cross Histocompatibility laboratories (Charlotte, NC and Portland, OR) were screened using both PAK-LX (Werfen, Inc) and SAB (ThermoFisher, Inc). Data included demographics, antibody positivity, discordance rates, mean fluorescence intensity (MFI), and calculated panel reactive antibody (cPRA).<br />Results: SAB detected HLA class I antibodies in 73% of participants; 36% showed discordance, with 98% being PAK-LX false negatives. Mean cPRA among discordant cases was 29% (range: 2-96%). Missed antibodies had MFIs typically below 6,000 but ranged from 2,000 to 19,000.<br />Conclusion: PAK-LX demonstrates reduced sensitivity for the detection of HLA class I antibodies compared with single-antigen bead (SAB) assays and may fail to identify HLA alloantibodies implicated in immune-mediated platelet transfusion refractoriness. Accordingly, PAK-LX should not be used as a standalone screening assay, and confirmatory testing with SAB is recommended when immune-mediated platelet refractoriness is suspected.<br /> (Copyright © 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.) – Name: Abstract Label: Competing Interests Group: Ab Data: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Alloimmunization; Human leukocyte antigens; Platelet refractoriness – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Isoantibodies)<br />0 (Histocompatibility Antigens Class I) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260313 <i>Date Completed: </i>20260710 <i>Latest Revision: </i>20260710 – Name: DateUpdate Label: Update Code Group: Date Data: 20260711 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.humimm.2026.111711 – Name: AN Label: PMID Group: ID Data: 41825092 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41825092 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.humimm.2026.111711 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 111711 Subjects: – SubjectFull: Humans Type: general – SubjectFull: Female Type: general – SubjectFull: Reproducibility of Results Type: general – SubjectFull: Male Type: general – SubjectFull: Adult Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Isoantibodies blood Type: general – SubjectFull: Histocompatibility Antigens Class I immunology Type: general – SubjectFull: Histocompatibility Testing methods Type: general – SubjectFull: Blood Platelets immunology Type: general – SubjectFull: Platelet Transfusion Type: general Titles: – TitleFull: Assessing the reliability of the PAK-LX HLA Class I bead in platelet transfusion compatibility testing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Enten H – PersonEntity: Name: NameFull: Liacini A – PersonEntity: Name: NameFull: Janes D – PersonEntity: Name: NameFull: Stedem R – PersonEntity: Name: NameFull: Gaule L – PersonEntity: Name: NameFull: Berka N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-1166 Numbering: – Type: volume Value: 87 – Type: issue Value: 5 Titles: – TitleFull: Human immunology Type: main |
| ResultId | 1 |